Clinical Trial Detail

NCT ID NCT02197234
Title Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

lung non-small cell carcinoma

Therapies

Osimertinib + Simvastatin

Simvastatin

Osimertinib

Age Groups: adult senior

No variant requirements are available.